会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Benzazepine derivatives
    • 苯扎西平衍生物
    • US4604389A
    • 1986-08-05
    • US732204
    • 1985-05-08
    • Manfred ReiffenKlaus NollJoachim HeiderVolkhard AustelNorbert HauelWalter KobingerChristian Lillie
    • Manfred ReiffenKlaus NollJoachim HeiderVolkhard AustelNorbert HauelWalter KobingerChristian Lillie
    • A61K31/55A61P9/06C07C59/64C07D223/16C07D233/16C07D243/04C07D405/12C07D491/04C07D491/056C07D521/00
    • C07D223/16C07C59/64C07D243/04C07D405/12C07D491/04
    • This invention relates to benzazepine derivatives of formula I ##STR1## wherein A is --CH.sub.2 CH.sub.2 -- or --CH.dbd.CH--;R.sub.1 is hydrogen, chlorine, bromine, C.sub.1 -C.sub.3 alkyl, amino, C.sub.1 -C.sub.3 alkylamino, C.sub.1 -C.sub.3 dialkylamino, acylamino, hydroxy, C.sub.1 -C.sub.3 alkoxy or phenyl C.sub.1 -C.sub.3 alkoxy;R.sub.2 is hydrogen, chlorine, bromine, hydroxy, C.sub.1 -C.sub.3 alkyl, C.sub.1 -C.sub.3 alkoxy or phenyl C.sub.1 -C.sub.3 alkoxy or, together with R.sub.1, can be C.sub.1 -C.sub.3 alkylenedioxy;R.sub.3 is hydrogen, chlorine, bromine or C.sub.1 -C.sub.3 alkoxy;R.sub.4 is hydrogen, benzyl, C.sub.1 -C.sub.3 alkyl or C.sub.3 -C.sub.5 alkenyl;R.sub.5 is hydrogen, halogen, C.sub.1 -C.sub.3 alkyl or C.sub.1 -C.sub.3 alkoxy;R.sub.6 is hydrogen, C.sub.1 -C.sub.3 alkyl or C.sub.1 -C.sub.3 alkoxy or, together with R.sub.5, can be a C.sub.1 -C.sub.2 alkylenedioxy;X is an imino, optionally substituted by a benzyl or C.sub.1 -C.sub.3 alkyl, or is oxygen, sulphur, sulphinyl or sulphonyl;Y is an imino, optionally substituted by a benzyl or C.sub.1 -C.sub.3 alkyl, or is methylene or carbonyl;m and n are each independently 2, 3 or 4; and nontoxic, pharmaceutically acceptable addition salts thereof. These compounds have valuable pharmacological properties, particularly the effect of lowering heart rate and reducing the O.sub.2 requirement of the heart.
    • 本发明涉及式I的苯并氮杂衍生物,其中A是-CH 2 CH 2 - 或-CH = CH-; R1是氢,氯,溴,C1-C3烷基,氨基,C1-C3烷基氨基,C1-C3二烷基氨基,酰氨基,羟基,C1-C3烷氧基或苯基C1-C3烷氧基; R2是氢,氯,溴,羟基,C1-C3烷基,C1-C3烷氧基或苯基C1-C3烷氧基,或与R1一起可以是C1-C3亚烷基二氧基; R3是氢,氯,溴或C1-C3烷氧基; R4是氢,苄基,C1-C3烷基或C3-C5烯基; R5是氢,卤素,C1-C3烷基或C1-C3烷氧基; R 6是氢,C 1 -C 3烷基或C 1 -C 3烷氧基,或与R 5一起可以是C 1 -C 2亚烷基二氧基; X是任选被苄基或C 1 -C 3烷基取代的亚氨基,或是氧,硫,亚磺酰基或磺酰基; Y是任选被苄基或C 1 -C 3烷基取代的亚氨基,或亚甲基或羰基; m和n各自独立地为2,3或4; 和无毒的药学上可接受的加成盐。 这些化合物具有有价值的药理学特性,特别是降低心率并降低心脏O2需求的作用。
    • 10. 发明授权
    • Esters and amides containing the
1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetyl moiety
    • 含有1-(4-氯苯甲酰基)-5-甲氧基-2-甲基-1H-吲哚-3-乙酰基部分的酯和酰胺
    • US4362738A
    • 1982-12-07
    • US158587
    • 1980-06-11
    • Johannes KeckGerd KrugerHelmut PieperKlaus NollGunther EngelhardtNorbert PrombergerRainer Zimmermann
    • Johannes KeckGerd KrugerHelmut PieperKlaus NollGunther EngelhardtNorbert PrombergerRainer Zimmermann
    • C07D209/08A61K31/495A61P29/00C07C67/00C07C227/00C07C227/16C07C227/18C07C229/54C07C237/32C07C237/38C07C313/00C07C323/12C07C323/65C07D209/28C07D213/74C07D295/088C07D295/155C07D401/12C07H13/08C07D279/18A61K27/00
    • C07D213/74C07D209/28C07D295/088C07D295/155
    • Compounds of the formula ##STR1## wherein each X, which may be identical or different from the other X, is oxygen or imino;R.sub.1 is hydrogen, fluorine, chlorine or bromine;R.sub.2 and R.sub.3, which may be identical or different from each other, are each hydrogen; unsubstituted or mono-substituted alkyl of 1 to 6 carbon atoms, where the substituent is phenyl or dialkylamino with 1 to 3 carbon atoms in each alkyl moiety; pyridyl; or cycloalkyl of 5 to 7 carbon atoms;R.sub.2 and R.sub.3, together with each other and the nitrogen atoms to which they are attached, are pyrrolidino, piperidino, hexamethyleneimino, morpholino, N-aryl-piperazino or N-(alkyl of 1 to 3 carbon atoms)-piperazino;A is cycloalkylene of 5 to 7 carbon atoms; unsubstituted or substituted alkylene of 2 to 10 carbon atoms, where the substituents are one to two alkyls of 1 to 3 carbon atoms each, one to two carbalkoxys of 2 to 4 carbon atoms each, one to two phenyls, one to four hydroxyls, one halomethyl, one hydroxymethyl, one alkanoyloxy of 1 to 18 carbon atoms, one alkanoyloxymethyl of 1 to 18 carbon atoms in the alkanoyl moiety or one ##STR2## where R.sub.1, R.sub.2 and R.sub.3 have the meanings previously defined; or alkylene of 2 to 10 carbon atoms interrupted by oxygen, sulfur, sulfoxide, sulfonyl, phenyl, cyclohexyl, pyridyl, piperazino or unsubstituted or substituted imino, where the substituent on the imino group is alkyl of 1 to 6 carbon atoms, phenyl or phenylalkyl of 1 to 3 carbon atoms in the alkyl moiety;B is the acyl residue of an antiphlogistic carboxylic acid;and their non-toxic, pharmacologically acceptable acid addition salts. The compounds as well as their salts are useful as anti-inflammatories.
    • 其中每个X可以相同或不同于另一个X的式“IMAGE”的化合物是氧或亚氨基; R1是氢,氟,氯或溴; R2和R3可以相同或不同,分别为氢; 未取代或单取代的1至6个碳原子的烷基,其中取代基为苯基或每个烷基部分具有1至3个碳原子的二烷基氨基; 吡啶基 或5至7个碳原子的环烷基; 吡咯烷基,哌啶子基,六亚甲基亚氨基,吗啉代,N-芳基 - 哌嗪子基或N-(1至3个碳原子的烷基) - 哌嗪基; R 2和R 3彼此连接并连接的氮原子。 A是5至7个碳原子的亚环烷基; 2至10个碳原子的未取代或取代的亚烷基,其中取代基为1至2个碳原子数为1至2个的烷基,每个为2至4个碳原子的1至2个碳烷氧基,1至2个苯基,1至4个羟基,1至2个 卤代甲基,一个羟甲基,一个1至18个碳原子的烷酰氧基,一个在烷酰基部分中具有1至18个碳原子的烷酰氧基甲基或一个,其中R1,R2和R3具有以前定义的含义; 或由氧,硫,亚砜,磺酰基,苯基,环己基,吡啶基,哌嗪子基或未取代或取代的亚氨基所取代的2至10个碳原子的亚烷基,其中亚氨基上的取代基是1至6个碳原子的烷基,苯基或苯基烷基 在烷基部分中具有1至3个碳原子; B是消炎性羧酸的酰基残基; 及其无毒,药理学上可接受的酸加成盐。 化合物及其盐可用作抗炎剂。